Literature DB >> 16318909

Regulation of FasL expression: a SH3 domain containing protein family involved in the lysosomal association of FasL.

Jing Qian1, Wenbin Chen, Marcus Lettau, Graziella Podda, Martin Zörnig, Dieter Kabelitz, Ottmar Janssen.   

Abstract

As a death factor of T cells and Natural Killer (NK) cells, Fas Ligand (FasL) is stored in association with secretory lysosomes. Upon stimulation, these cytotoxic granules are transported to the cell membrane where FasL is exposed on the cell surface, shed or secreted. It has been noted before that the proline-rich domain within the cytosolic part of FasL is required for its vesicular association. However, the molecular interactions involved in targeting FasL to secretory lysosomes or to the plasma membrane have not been elucidated. We now identified a family of structurally related proteins that upon co-expression with FasL reallocate the death factor from a membrane to an intracellular localization. Members of this protein family are characterized by a similar domain structure and include FBP17, PACSIN1-3, CD2BP1, CIP4, Rho-GAP C1 and several hypothetical proteins. We show that all tested members of this "FCH/SH3-family" co-precipitate FasL from transfectants. The interactions strictly depend on functional SH3 domains within the FCH/SH3 proteins. Since co-expression of FasL with individual FCH/SH3 proteins dramatically alters the intracellular localization of FasL especially in non-hematopoietic cells, our data suggest that FCH/SH3 proteins might play an important role for the subcellular distribution and lysosomal association of FasL.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16318909     DOI: 10.1016/j.cellsig.2005.10.015

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  9 in total

Review 1.  Control of death receptor ligand activity by posttranslational modifications.

Authors:  R Weinlich; T Brunner; G P Amarante-Mendes
Journal:  Cell Mol Life Sci       Date:  2010-03-20       Impact factor: 9.261

2.  Clinical, Molecular, and Genetic Characteristics of PAPA Syndrome: A Review.

Authors:  Elisabeth J Smith; Florence Allantaz; Lynda Bennett; Dongping Zhang; Xiaochong Gao; Geryl Wood; Daniel L Kastner; Marilynn Punaro; Ivona Aksentijevich; Virginia Pascual; Carol A Wise
Journal:  Curr Genomics       Date:  2010-11       Impact factor: 2.236

3.  Primed innate immunity leads to autoinflammatory disease in PSTPIP2-deficient cmo mice.

Authors:  Violeta Chitu; Polly J Ferguson; Rosalie de Bruijn; Annette J Schlueter; Luis A Ochoa; Thomas J Waldschmidt; Yee-Guide Yeung; E Richard Stanley
Journal:  Blood       Date:  2009-07-16       Impact factor: 22.113

4.  Effector granules in human T lymphocytes: the luminal proteome of secretory lysosomes from human T cells.

Authors:  Hendrik Schmidt; Christoph Gelhaus; Melanie Nebendahl; Marcus Lettau; Ralph Lucius; Matthias Leippe; Dietrich Kabelitz; Ottmar Janssen
Journal:  Cell Commun Signal       Date:  2011-01-21       Impact factor: 5.712

Review 5.  Intra- and Extracellular Effector Vesicles From Human T And NK Cells: Same-Same, but Different?

Authors:  Marcus Lettau; Ottmar Janssen
Journal:  Front Immunol       Date:  2021-12-23       Impact factor: 7.561

Review 6.  The Serine Protease CD26/DPP4 in Non-Transformed and Malignant T Cells.

Authors:  Guranda Chitadze; Ulrike Wehkamp; Ottmar Janssen; Monika Brüggemann; Marcus Lettau
Journal:  Cancers (Basel)       Date:  2021-11-26       Impact factor: 6.639

7.  Identification of SH3 domain interaction partners of human FasL (CD178) by phage display screening.

Authors:  Matthias Voss; Marcus Lettau; Ottmar Janssen
Journal:  BMC Immunol       Date:  2009-10-06       Impact factor: 3.615

8.  Posttranslational regulation of Fas ligand function.

Authors:  Matthias Voss; Marcus Lettau; Maren Paulsen; Ottmar Janssen
Journal:  Cell Commun Signal       Date:  2008-12-29       Impact factor: 5.712

9.  Identification of SH3 domain proteins interacting with the cytoplasmic tail of the a disintegrin and metalloprotease 10 (ADAM10).

Authors:  Henriette Ebsen; Marcus Lettau; Dieter Kabelitz; Ottmar Janssen
Journal:  PLoS One       Date:  2014-07-18       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.